2006 Biostatistics Seminar/Workshop Series

December

• Statistical Consultations Across Client Domains?, by Ken Wright, Graduate Student and Roger Hall, PhD, Department of Teaching and Learning, Peabody College at Vanderbilt University December 13; 1:30-2:30pm, MRBIII 1220
• Sensitivity Analysis and Informative Priors for Longitudinal Data with Informative Dropout?, by Joseph Hogan, ScD, Center for Statistical Sciences-- Biostatistics, Brown University December 6; 1:30-2:30pm, MRBIII 1220

November

• Conditional Likelihood Methods for Haplotype-based Association Analysis Using Matched Case-Control Data ?, by Jinbo Chen, PhD, Department of Biostatistics, University of Pennsylvania November 29; 1:30-2:30pm, MRBIII 1220
• Are Boec Cells More Like Large Vessel or Microvascular Endothelial Celss or Neither of Them??, by Aixiang Jiang, MS, Shared Resources Cancer Center, Division of Biostatistics, Vanderbilt University November 15; 1:30-2:30pm, MRBIII 1220
• Computing functional MRI activation from spatial frequencies?, by Daniel Rowe, PhD, Department of Biophysics, Division of Biostatistics, Medical College of Wisconsin November 8; 1:30-2:30pm, MRBIII 1220
• The End of Significance?, by Jonathan Sterne, PhD, Department of Social Medicine, University of Bristol November 2; 10-11am, MRBIII 3131
• Randomized versus observational studies? The case of postmenopausal hormone therapy and coronary heart disease?, by Miguel Hernan, MD, DrPH, Department of Epidemiology, Harvard University November 1; 1:30-2:30pm, MRBIII 1220

October

• An Alternative Double Robustness Method for Estimating Population Means from Imcomplete Data?, by Qingxia (Cindy) Chen, PhD, Assistant Professor , Department of Biostatistics, Vanderbilt University October 18; 1:30-2:30pm, MRBIII 1220
• Musings on the nature of data analysis?, by Rafe Donahue, PhD, Research Associate Professor , Department of Biostatistics, Vanderbilt University October 11; 1:30-2:30pm, MRBIII 1220
• Randomized versus observational therapeutic studies: is there a battle??, by Karel Moons, PhD, Julius Center for Health Sciences and Primary Care Research, University of Utrecht, Netherlands October 4; 1:30-2:30pm, MRBIII 1220

September

• The Causal Effect of Finasteride on the Severity of Prostate Cancer?, by Bryan Shepherd, PhD, Assistant Professor , Department of Biostatistics, Vanderbilt University September 20; 1:30-2:30pm, MRBIII 1220
• Evaluating physician's risk for malpractice - a Bayesian approach?, by Chuan Zhou, PhD, Assistant Professor , Department of Biostatistics, Vanderbilt University September 13; 1:30-2:30pm, MRBIII 1220
• Cancer Epidemiology at Vanderbilt?, by Wei Zheng, MD, PhD, MPH, Professor of Medicine, Vanderbilt University September 6; 1:30-2:30pm, MRBIII 1220

July

• Methodologic challenges in HIV prevention research?, by Sten Vermund, MD PhD, Director of the Institute for Global Health, Vanderbilt University July 19; 1:30-2:20pm, MRBIII 1220
• Developing and validating prognostic models for health outcomes using modern analytical tools?, by Frank Harrell, PhD, Department of Biostatistics, Vanderbilt University July 12; 10-11am, MRBIII 3131 PLEASE NOTICE THE ROOM CHANGE

June

• Using subversion for collaboration and file consistency?, by the IT group, Department of Biostatistics, Vanderbilt University June 28; 1:30-2:30pm, Conference room MRBIII 1220
• Adjusting for the onset of a risk factor analyzing common clinical outcomes: Application to the Stanford Heart Study and ICU Delirium Study?, by Ayumi Shintani, Ph.D., M.P.H., Department of Biostatistics, Vanderbilt University June 14; 1:30-2:30pm, Conference room MRBIII 1220
• A Semiparametric Regression Model for Zero-Inflated Count?, by Chin-Shang Li, Ph.D., St. Jude Children's Hospital June 7; 1:30-2:30pm, Conference room MRBIII 1220

May

• Infant Viral Exposure and Timing of Infection on the Risk of Childhood Asthma?, by Pingsheng Wu, Ph.D., Vanderbilt University May 31; 1:30-2:30pm, Conference room MRBIII 1220
• E-mail Tips and Installing R Packages Locally?, by the IT group, Department of Biostatistics, Vanderbilt University May 24; 1:30-2:30pm, Conference room MRBIII 1220
• Flexible longitudinal regression modeling of clinical lab data for early detection of drug toxicity?, by Jonathan S. Schildcrout, Ph.D., Department of Biostatistics, Vanderbilt University May 17; 1:30-2:30pm, Conference room MRBIII 1220
• Joint models for the association between longitudinal binary and continuous processes?, by Mike Daniels, Ph.D., Department of Statistics, University of Florida May 10; 1:30-2:30pm, Conference room MRBIII 1220
• The trials and tribulations of a randomized clinical trial?, by Kathryn Edwards, M.D., Department of Pediatrics, Vanderbilt University May 3; 1:30-2:30pm, Conference room MRBIII 1220

April

• Demystifying Double Robustness: A Comparison of Alternative Strategies for Estimating a Population Mean from Incomplete Data ?, by Joseph L. Schafer, Ph.D., Department of Statistics and The Methodology Center, Penn State University April 26; 1:30-2:30pm, Conference room MRBIII 1220
• Entropy measures of physiological time series - concept, application, and challenges?, by Susan Cao, Ph.D., Vanderbilt University April 19; 10-11am, Conference room MRBIII 3131
• The Conditionality Principle and 2x2 Contingency Tables: Some Thoughts on the Foundations of Statistical Inference: Part II?, by William D. DuPont, Ph.D. and Leena Choi, Ph.D., Department of Biotatistics, Vanderbilt University; Apr 12; 1:30-2:30pm,Conference room MRBIII 1220
• The Conditionality Principle and 2x2 Contingency Tables: Some Thoughts on the Foundations of Statistical Inference: Part I?, by William D. DuPont, Ph.D. and Leena Choi, Ph.D., Department of Biotatistics, Vanderbilt University; Apr 5; 10-11am, Conference room MRBIII 3131

March

• GEE with large cluster sizes: high-dimensional working correlation models?, by Hyoju Chung, Ph.C., Department of Biotatistics, University of Washington; March 22; 10-11am, Conference room MRBIII 3131
• Characterizing the Genetic Structure of Populations?, by Steven Chen, Ph.C., Department of Statistics, North Carolina State University; March 16; 4-5pm, Conference room Preston Research Building, room 898B. PLEASE NOTICE THE ROOM CHANGE
• Multivariate Bayes Methods for Analysis of Medically Related Adverse Events in Clinical Trials?, by William DuMouchel, Ph.D., Chief Statistical Scientist, Lincoln Technologies; March 15; 10-11am, Conference room MRBIII 3131
• Comparative Mass Spectrometry?, by Heinrich Roder, D. Phil, Efeckta Technologies March 8; 10-11am, Conference room MRBIII 3131. Jointly Sponsored by the Mass Spectrometry Research Center and the Department of Biostatistics
• Symmetrized Percent Change for Treatment Comparisons?, by Dan Ayers, M.S., University of Texas MD Anderson Cancer Research Center March 1; 10-11am, Conference room MRBIII 3131

February

• Quality-of-life adjusted analyses of successive events?, by Adin-Cristian Andrei, Ph.D., Department of Biostatistics, University of Michigan, being rescheduled; TBA, Conference room MRBIII 3131
• Estimating the Success Rate of Two Diagnostic Tests where Test 1 Dominates Test 2 ?, by Chang Yu, Ph.D., Department of Biostatistics, Vanderbilt University, February 15; 10-11a, Conference room MRBIII 3131
• Frequentist and Bayesian Two-Stage Designs in Phase II Clinical Trials ?, by Ming Li, Ph.D., Department of Biostatistics, Vanderbilt University, February 1; 10-11a, Conference room MRBIII 3131

January

• Heart Rate Variability and Dense Physiologic Data Capture: Update on Physiologic Biomarkers in the Intensive Care Unit ?, by John Morris, MD, Department of Surgery, Vanderbilt University, January 18; 10-11a, Conference room MRBIII 3131
• Regression Modeling Strategies, Five-Day Short Course?, By Frank E. Harrell, Ph.D., Professor and Chair, Department of Biostatistics (Registration is Required)
• Why Bayes? Innovations in Clinical Trial Design and Analysis ?, by Donald Berry, Ph.D., Department of Biostatistics, MD Anderson Cancer Research Center, January 11; 10-11a, Conference room MRBIII 3131
• Measuring the burden of influenza-related illness ?, by Marie Griffin, MD MPH, Department of Preventive Medicine, Vanderbilt University Medical Center, January 4; 10-11a, Conference room MRBIII 3131